Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$76
|
$217B |
3.4x |
7.9x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$177B |
2.8x |
7.3x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€93
|
$142B |
2.8x |
9.5x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$97.5B |
2.3x |
6.6x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 248
|
$87.5B |
5.7x |
16.9x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€155
|
$34.5B |
4.8x |
17.9x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 69
|
$11.7B |
N/A |
N/A |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$100
|
$8.4B |
3.1x |
-6.2x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$8.1B |
2.4x |
19.8x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3269
|
$6.2B |
13.9x |
44.3x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 178
|
$6.0B |
6.8x |
25.0x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$27
|
$5.2B |
1.9x |
-1.4x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.7B |
5.9x |
14.6x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 40
|
$2.8B |
7.5x |
46.2x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.8B |
57.1x |
N/A |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$33
|
$2.6B |
N/A |
N/A |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 14
|
$2.5B |
6.2x |
22.6x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 7919
|
$2.3B |
N/A |
N/A |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 10
|
$1.9B |
4.7x |
22.5x |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 173
|
$1.9B |
2.1x |
7.1x |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 43200
|
$1.8B |
6.2x |
-49.6x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 44
|
$1.7B |
11.6x |
-19.9x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 14748
|
$1.5B |
N/A |
N/A |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 21
|
$1.2B |
6.8x |
23.9x |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€28
|
$1.2B |
N/A |
N/A |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$1.1B |
5.8x |
8.2x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 7
|
$985M |
5.4x |
20.9x |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$919M |
6.4x |
12.9x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 54
|
$897M |
4.4x |
11.4x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$797M |
2.7x |
21.1x |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 9
|
$783M |
10.8x |
11.7x |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 4
|
$774M |
4.1x |
N/A |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 26
|
$761M |
3.2x |
10.3x |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$7
|
$662M |
0.8x |
13.2x |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$20
|
$647M |
115.5x |
-3.1x |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 4
|
$638M |
11.7x |
-30.5x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€3
|
$598M |
3.0x |
102.4x |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$584M |
N/A |
N/A |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$5
|
$584M |
1.5x |
6.5x |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 471
|
$582M |
N/A |
N/A |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 8
|
$577M |
N/A |
-9.7x |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 52
|
$515M |
24.0x |
157.7x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$492M |
6.3x |
-19.7x |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 21
|
$488M |
453.4x |
-24.0x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$466M |
65.9x |
-1.8x |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$452M |
N/A |
N/A |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 380
|
$410M |
1.8x |
N/A |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$370M |
81.0x |
-20.6x |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$338M |
3.9x |
-3.1x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 24
|
$328M |
1.9x |
8.6x |
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$325M |
2.7x |
18.8x |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$315M |
31.8x |
-1.1x |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 19
|
$282M |
N/A |
N/A |
Coherus BioSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$280M |
1.6x |
-2.7x |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 24
|
$266M |
1.4x |
6.6x |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$258M |
N/A |
N/A |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$250M |
784.9x |
N/A |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$238M |
69.4x |
N/A |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$212M |
N/A |
-6.0x |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 40
|
$208M |
N/A |
N/A |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$187M |
363.8x |
N/A |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$30
|
$182M |
N/A |
N/A |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$161M |
1.5x |
N/A |
INmune Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$152M |
6418.2x |
N/A |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 18
|
$148M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$144M |
N/A |
N/A |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9500
|
$137M |
N/A |
N/A |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€6
|
$135M |
1.8x |
3.8x |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 22
|
$134M |
N/A |
N/A |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$130M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$123M |
N/A |
N/A |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$120M |
159.9x |
N/A |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$107M |
N/A |
N/A |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$93.2M |
3.8x |
N/A |
Vaxart
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$81.5M |
3.2x |
N/A |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$78.8M |
3.4x |
-3.5x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$73.3M |
35.5x |
-0.7x |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$73.3M |
0.7x |
-22.5x |
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$10
|
$70.0M |
0.3x |
-0.2x |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$68.7M |
N/A |
N/A |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$65.7M |
0.5x |
-0.8x |
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$65.6M |
40.9x |
-0.8x |
LakeShore Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$64.9M |
N/A |
N/A |
Adaptimmune Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$61.5M |
0.5x |
-0.8x |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$61.0M |
N/A |
N/A |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$59.5M |
12629.2x |
-2.5x |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$59.4M |
3218.9x |
-0.2x |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$54.5M |
0.9x |
-0.5x |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$53.6M |
11.9x |
N/A |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$47.9M |
N/A |
-2.2x |
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$44.4M |
N/A |
-0.5x |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$43.0M |
N/A |
-1.1x |
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$42.5M |
4.8x |
N/A |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€4
|
$38.2M |
N/A |
N/A |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$36.1M |
N/A |
N/A |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$33.7M |
1.5x |
N/A |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$29.6M |
N/A |
N/A |
HCW Biologics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$28.3M |
6.4x |
N/A |
Adagene
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$25.4M |
341.0x |
-0.7x |
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$21.0M |
121.5x |
N/A |